These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

721 related articles for article (PubMed ID: 19446000)

  • 1. Tolerance in DLA-haploidentical canine littermates following CD6-depleted marrow transplantation and donor lymphocyte transfusion.
    Zorn J; Herber M; Schwamberger S; Panzer W; Adler H; Kolb HJ
    Exp Hematol; 2009 Aug; 37(8):998-1006. PubMed ID: 19446000
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transplantation of CD6-depleted peripheral blood stem cells after DLA-haploidentical bone marrow transplantation contributes to engraftment and tolerance in a preclinical model of stem cell transplantation.
    Zorn J; Schwamberger S; Panzer W; Adler H; Kolb HJ
    Vet Immunol Immunopathol; 2011 Nov; 144(1-2):27-35. PubMed ID: 21784536
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevention of graft-versus-host disease in DLA-haplotype mismatched dogs and hemopoietic engraftment of CD6-depleted marrow with and without cG-CSF treatment after transplantation.
    Schumm M; Günther W; Kolb HJ; Rieber P; Büttner M; Voss C; Kremmer E; Reitmeier P; Thierfelder S; Wilmanns W
    Tissue Antigens; 1994 Mar; 43(3):170-8. PubMed ID: 7522357
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A new marrow T cell depletion method using anti-CD6 monoclonal antibody-conjugated magnetic beads and its clinical application for prevention of acute graft-vs.-host disease in allogeneic bone marrow transplantation: results of a phase I-II trial.
    Sao H; Kitaori K; Kasai M; Shimokawa T; Kato C; Yamanishi H; Ueda R; Morishima Y
    Int J Hematol; 1999 Jan; 69(1):27-35. PubMed ID: 10641440
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Selective T cell depletion of donor allogeneic marrow with anti-CD6 monoclonal antibody: rationale and results.
    Soiffer RJ; Ritz J
    Bone Marrow Transplant; 1993; 12 Suppl 3():S7-10. PubMed ID: 8124262
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CD6+ T cell-depleted allogeneic bone marrow transplantation for non-Hodgkin's lymphoma.
    Soiffer RJ; Freedman AS; Neuberg D; Fisher DC; Alyea EP; Gribben J; Schlossman RL; Bartlett-Pandite L; Kuhlman C; Murray C; Freeman A; Mauch P; Anderson KC; Nadler LM; Ritz J
    Bone Marrow Transplant; 1998 Jun; 21(12):1177-81. PubMed ID: 9674848
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hematopoietic chimerism induces renal and skin allograft tolerance in DLA-identical dogs.
    Tillson M; Niemeyer GP; Welch JA; Brawner W; Swaim SF; Rynders P; Lenz SD; Dean B; Lothrop CD
    Exp Hematol; 2006 Dec; 34(12):1759-70. PubMed ID: 17157174
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Graft versus host tolerance in dogs across one DLA-haplotype by depletion of CD6 positive cells.
    Schumm M; Kolb HJ; Hahn J; Beisser K; Rieber P; Günther W; Büttner M; Wilmanns W; Thierfelder S
    Prog Clin Biol Res; 1992; 377():419-25. PubMed ID: 1438440
    [No Abstract]   [Full Text] [Related]  

  • 9. Renal allograft tolerance in DLA-identical and haploidentical dogs after nonmyeloablative conditioning and transient immunosuppression with cyclosporine and mycophenolate mofetil.
    Niemeyer GP; Welch JA; Tillson M; Brawner W; Rynders P; Goodman S; Dufresne M; Dennis J; Lothrop CD
    Transplant Proc; 2005 Dec; 37(10):4579-86. PubMed ID: 16387175
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tolerance and chimerism.
    Kolb HJ; Guenther W; Gyurkocza B; Hoetzl F; Simoes B; Falk C; Schleuning M; Ledderose G
    Transplantation; 2003 May; 75(9 Suppl):26S-31S. PubMed ID: 12819487
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-NK cell treatment induces stable mixed chimerism in MHC-mismatched, T cell-depleted, nonmyeloablative bone marrow transplantation.
    Cho SG; Shuto Y; Soda Y; Nakazaki Y; Izawa K; Uchimaru K; Takahashi S; Tani K; Tojo A; Asano S
    Exp Hematol; 2004 Dec; 32(12):1246-54. PubMed ID: 15588949
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term outcomes of nonconditioned patients with severe combined immunodeficiency transplanted with HLA-identical or haploidentical bone marrow depleted of T cells with anti-CD6 mAb.
    Patel NC; Chinen J; Rosenblatt HM; Hanson IC; Brown BS; Paul ME; Abramson SL; Ritz J; Shearer WT
    J Allergy Clin Immunol; 2008 Dec; 122(6):1185-93. PubMed ID: 19084111
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Leucyl-leucine methyl ester-treated haploidentical donor lymphocyte infusions can mediate graft-versus-leukemia activity with minimal graft-versus-host disease risk.
    Hsieh MH; Varadi G; Flomenberg N; Korngold R
    Biol Blood Marrow Transplant; 2002; 8(6):303-15. PubMed ID: 12108916
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sirolimus promotes tolerance for donor and recipient antigens after MHC class II disparate bone marrow transplantation in rats.
    Jäger MD; Liu JY; Timrott KF; Popp FC; Stoeltzing O; Lang SA; Piso P; Geissler EK; Schlitt HJ; Dahlke MH
    Exp Hematol; 2007 Jan; 35(1):164-70. PubMed ID: 17198885
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 'Resistance' to unrelated, DLA-nonidentical canine marrow grafts is unrestricted by the major histocompatibility complex.
    Raff RF; Sandmaier BM; Graham T; Loughran TP; Pettinger M; Storb R
    Exp Hematol; 1994 Aug; 22(9):893-7. PubMed ID: 8062888
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of recombinant canine stem cell factor, a c-kit ligand, on hematopoietic recovery after DLA-identical littermate marrow transplants in dogs.
    Schuening FG; von Kalle C; Kiem HP; Appelbaum FR; Deeg HJ; Pepe M; Gooley T; Graham TC; Hackman RC; Storb R
    Exp Hematol; 1997 Nov; 25(12):1240-5. PubMed ID: 9357967
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A second prophylactic MHC-mismatched bone marrow transplantation protects against rat acute myeloid leukemia (BNML) without lethal graft-versus-host disease.
    Nestvold JM; Omdal BK; Dai KZ; Martens A; Benestad HB; Vaage JT; Rolstad B
    Transplantation; 2008 Jan; 85(1):102-11. PubMed ID: 18192919
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Induction of allogeneic unresponsiveness in adult dogs. Role of non-DLA histocompatibility variables in conditioning the outcome of bone marrow, kidney, and skin transplantation in radiation chimeras.
    Rapaport FT; Bachvaroff RJ; Watanabe K; Hirasawa H; Mollen N; Ferrebee JW; Amos DB; Cannon FD; Blumenstock DA
    J Clin Invest; 1978 Mar; 61(3):790-800. PubMed ID: 76636
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A modified haploidentical nonmyeloablative transplantation without T cell depletion for high-risk acute leukemia: successful engraftment and mild GVHD.
    Guo M; Sun Z; Sun QY; Han Q; Yu CL; Wang DH; Qiao JH; Chen B; Sun WJ; Hu KX; Liu GX; Liu B; Zhao RC; Ai H
    Biol Blood Marrow Transplant; 2009 Aug; 15(8):930-7. PubMed ID: 19589482
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recipient-specific donor cytotoxic T lymphocytes enhance engraftment of unrelated, DLA non-identical canine marrow.
    Schwarzinger I; Raff RF; Flowers M; Niederwieser D; Graham T; Shulman H; Appelbaum FR; Schuening F; Storb R
    Bone Marrow Transplant; 1994 Mar; 13(3):303-9. PubMed ID: 8199572
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 37.